Role of ALADIN in Human Adrenocortical Cells for Oxidative Stress Response and Steroidogenesis

Ramona Jühlen; Jan Idkowiak; Angela E. Taylor; Barbara Kind; Wiebke Arlt; Angela Huebner; Katrin Koehler

doi:10.1371/journal.pone.0124582

Abstract

Triple A syndrome is caused by mutations in AAAS encoding the protein ALADIN. We investigated the role of ALADIN in the human adrenocortical cell line NCI-H295R1 by either over-expression or down-regulation of ALADIN. Our findings indicate that AAAS knock-down induces a down-regulation of genes coding for type II microsomal cytochrome P450 hydroxylases CYP17A1 and CYP21A2 and their electron donor enzyme cytochrome P450 oxidoreductase, thereby decreasing biosynthesis of precursor metabolites required for glucocorticoid and androgen production. Furthermore we demonstrate that ALADIN deficiency leads to increased susceptibility to oxidative stress and alteration in redox homeostasis after paraquat treatment. Finally, we show significantly impaired nuclear import of DNA ligase 1, aprataxin and ferritin heavy chain 1 in ALADIN knock-down cells. We conclude that down-regulating ALADIN results in decreased oxidative stress response leading to alteration in steroidogenesis, highlighting our knock-down cell model as an important in-vitro tool for studying the adrenal phenotype in triple A syndrome.

Citation: Jühlen R, Idkowiak J, Taylor AE, Kind B, Arlt W, Huebner A, et al. (2015) Role of ALADIN in Human Adrenocortical Cells for Oxidative Stress Response and Steroidogenesis. PLoS ONE 10(4): e0124582. https://doi.org/10.1371/journal.pone.0124582

Academic Editor: Yoshiaki Tsuji, North Carolina State University, UNITED STATES

Received: December 22, 2014; Accepted: March 4, 2015; Published: April 13, 2015

Copyright: © 2015 Jühlen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: This work was supported by a Deutsche Forschungsgemeinschaft grant HU 895/5-1 (Clinical Research Unit 252) to AH, a Visiting Scholarship of the European Society for Paediatric Endocrinology awarded to RJ and the Medical Research Council UK (Program Grant 0900567, to WA; Research Training Fellowship G1001964, to JI, http://www.dfg.de/, http://www.eurospe.org/, http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Triple A syndrome (MIM*231550) is an autosomal-recessive disease manifesting with the triad of ACTH-resistant adrenal insufficiency, achalasia of the cardia and alacrima (Triple A) in combination with progressive neurological impairment [1]. The disease is caused by mutations in the AAAS (achalasia—adrenocortical insufficiency—alacrima syndrome) gene, which encodes the protein ALADIN (alacrima-achalasia-adrenal insufficiency neurologic disorder) [2,3]. AAAS is ubiquitously expressed, but shows an enhanced expression in the adrenal gland, gastrointestinal tract and pituitary gland [3]. In 2002, ALADIN was identified as a component of the nuclear pore complex (NPC) [4]. Human NPC is a large protein complex composed of approximately 30 different proteins, known as nucleoporins, which mediate the transport of macromolecules between the cytoplasm and the nucleoplasm [4]. Most of the known AAAS mutations result in mis-localisation of the altered ALADIN protein, mainly to the cytoplasm [5–7]. ALADIN is anchored within the NPC by the transmembrane nucleoporin NDC1 [8,9]. It belongs to the group of barely exchangeable nucleoporins and therefore seems to be a scaffold nucleoporin [10]. It is suspected that a dysfunction of ALADIN may play a role in cellular accumulation of reactive oxygen species (ROS). There is increasing evidence that ALADIN-deficient cells are more susceptible to oxidative stress [11–14]. During our ongoing investigations Prasad et al. recently published results on the involvement of ALADIN in oxidative stress response and steroidogenesis [12]. With our study we do not just reproduce results obtained by Prasad et al. but independently verify some of their aspects using an alternative cell model and present new results on the role of ALADIN for oxidative stress, steroidogenesis and nuclear import. The results discussed in this article therefore add to the understanding of the adrenal phenotype in triple A syndrome.

In addition, studying differential gene expression in ALADIN-deficient or-mutated cells under oxidative stress, we have previously seen that cells of triple A patients show an altered induction or down-regulation of genes associated with oxidative stress and antioxidant defence [13]. Ferritin heavy chain protein (FTH1) was identified as an interaction partner of ALADIN [14]. In addition to its well-known iron storage role, FTH1 has been shown to protect the nucleus from oxidative damage. It was hypothesised that mutant ALADIN impairs the nuclear import of FTH1 in triple A syndrome. A deficiency of nuclear FTH1 results in an enhanced susceptibility of cells to oxidative stress and cellular damage [14]. Furthermore Hirano et al. showed in a patient fibroblast cell line a reduced nuclear import of DNA ligase 1 (LIG1) and aprataxin (APTX) which both have functions in DNA single strand break repair, also demonstrating an increased sensitivity of those cells to oxidative stress [15].

Here, we investigated the cellular role of ALADIN by creating two experimental models using the adrenocortical tumour cell line NCI-H295R1, a sub-strain showing characteristics of the glucocorticoid-producing zona fasciculata of the adrenal cortex [16]. Cells were engineered to either over-express or down-regulate AAAS by inducible stable transfection. Subsequently, we investigated alterations in steroidogenic gene expression and assessed functional consequences by steroid quantification from cell supernatants employing a liquid chromatography/tandem mass spectrometry (LC/MS-MS) method for simultaneous quantification of 13 key steroids of the adrenal steroidogenic pathway. In addition, we examined the role of ALADIN on cell viability, oxidative stress response and nuclear import of aprataxin, DNA ligase 1 and ferritin heavy chain 1.

Materials and Methods

Plasmids and vector construction for short hairpin RNA silencing of gene expression and over-expression

For generation of the AAAS shRNA-inducible H295R cell clones, we employed the T-REx system (Invitrogen, Life Technologies, Darmstadt, Germany). Oligonucleotides were designed using the Ambion web-based software “siRNA Target Finder” and compared to the human genome database for no more than 16–17 contiguous base pairs of homology to other coding sequences using NCBI BLAST (www.ncbi.nlm.nih.gov/BLAST). We selected six regions to be the target sequence for shRNA silencing of AAAS (V1: NM_015665.5) and used the two best regions (nt279-299 AAATGAAATTGCAAACTCAGA and nt410-430 AAGATCTGATCGCTGAATTTG) for further experiments. As a negative control we used a non-targeting scrambled siRNA (AAAGTACTGCTTACGATACGG). To create pTER plasmids we used two complementary hairpin siRNA template oligonucleotides and ligated into BglII and HindIII restriction sites of the inducible small-interfering-RNA expression vector pTER, which was generously provided by Enzo Lalli [17]. The inducible pcDNA4/TO expression vector (Invitrogen, Life Technologies) was used for hAAAS cDNA over-expression. The full length hAAAS cDNA was cloned between HindIII and XhoI sites into 5’-de-phosphorylated pcDNA4/TO.

Investigation of nuclear import processes was done using C- or N-terminal fluorescent protein vectors (pFP C1 or pFP N3) (Takara Bio Europe/Clonetech, Saint-Germain-en-Laye, France). Full length cDNA of APTX (V1: NM_175073.2; V6: NM_001195248.1; V7: NM_001195249.1), LIG1 (V1: NM_000234.2) and FTH1 (V1: NM_002032.2) were cloned to create YFP-C1-LIG1, APTX-N3-YFP and FTH1-N3-YFP plasmids. All plasmids constructs were confirmed by DNA sequencing.

Cell culture and treatments

NCI-H295R1-TR cells containing a tetracycline response system were kindly provided by Enzo Lalli [18,19]. The cells were cultured in DMEM/F12 medium (Lonza, Cologne, Germany) supplemented with 5% Nu-serum (BD Biosciences), 1% insulin-tranferrin-selenium-X supplement (Gibco, Life Technologies), 1% antibiotic-antimycotic (100 U penicillin/ml, 0,1 mg/ml streptomycin sulphate and 0.25 μg/ml amphotericin B, PAA, GE Healthcare Europe GmbH, Freiburg, Germany) and 5 μg/ml blasticidin S (InvivoGen, Toulouse, France). Cells were maintained in a 37°C humidified atmosphere (5% CO₂).

For generation of NCI-H295R1-TR stably expressing AAAS shRNA (NCI-H295R1-TR AAAS knock-down), the cells were transfected with the two different pTER-AAAS1 and pTER-AAAS2 shRNA vectors or the scrambled pTER-shRNA vector as a control cell line (NCI-H295R1-TR scrambled shRNA). For generation of NCI-H295R1-TR stably expressing hAAAS cDNA (NCI-H295R1-TR AAAS over-expression), the pcDNA4/TO-AAAS cDNA was transfected into NCI-H295R1-TR. NCI-H295R1-TR cells stably expressing empty pcDNA4/TO were generated in addition without PCR product insert as a control cell line.

NCI-H295R1-TR cells with AAAS knock-down shRNA, scrambled shRNA, AAAS over-expression and pcDNA4/TO empty vector were selected and cultured with 100 μg/ml zeocin (InvivoGen, Toulouse, France) in culture media. Doxycyline hydrochloride (tetracycline analogue) (MP Biomedicals, Eschwege, Germany) was used at 1 μg/ml for 48 h to turn on the expression of the subsequent integrated gene or shRNA sequences. The most reliable sub-clones were selected and one clone per construct type was chosen (AAAS knock-down shRNA, scrambled shRNA, AAAS over-expression and pcDNA4/TO empty vector).

Selected cell lines were cultured in 6-well culture dishes (Corning Costar, Kaiserslautern, Germany) at a density of 2x10⁵ cells/well and treated 24 h after seeding with doxycycline for 48 h. In order to determine efficiency of AAAS knock-down, over-expression and expression of genes coding for steroidogenic enzymes total RNA was isolated from one well and used for real-time RT-PCR. In addition, whole protein was isolated from two wells and ALADIN expression was verified on protein level. Steroid production was determined by liquid chromatography tandem mass spectrometry of the cell media of three wells. Experiments were repeated six times.

For analysis of oxidative stress response cells were stimulated with 0.2 mM methyl viologen dichloride (paraquat) (Sigma-Aldrich, Munich, Germany) for 24 h.

Stable and transient adrenal cell transfection

Cells were cultured in 6-well culture dishes at a density of 1.6x10⁵ cells/well 24 h before subsequent transfections. Cells were transfected using X-tremeGENE HP DNA transfection reagent (Roche Diagnostics, Mannheim, Germany) following the manufacturer’s protocols. All plasmids were used at a concentration of 0.01 μg/μl at an optimised transfection ratio of 2:5 diluted in pure DMEM/F12.

For stable transfections, pTER and pcDNA4/TO constructs were linearised prior transfections by digestion with PvuI. At 50% confluency after transfection cells were split 1:4 and sub-cultured in 6-well culture dishes containing medium supplemented with 100 μg/ml zeocin. Clones appeared after approximately 4 weeks and were transferred each into one well of 24-well culture dishes (Corning Costar) by the use of cloning cylinders (Sigma-Aldrich). Clones were grown up and at a confluency of 70% split 1:3.

For transient transfections of pYFP C1-LIG1, APTX-N3 and FTH1-N3, 1.6x10⁵ cells of NCI-H295R1-TR AAAS knock-down, scrambled shRNA, AAAS over-expression and pcDNA4/TO empty were sub-cultured onto cover slips (Carl Zeiss, Jena, Germany) in 6-well culture dishes. During transfection doxycycline was added to the medium. After 24 h medium was changed and cells were grown for additional 24 h in the presence of doxycycline.

RNA extraction, cDNA synthesis and quantitative real-time PCR using TaqMan

After seeding, cells were induced with doxycycline for 48 h and total RNA was isolated using the NucleoSpin RNA II kit (Macherey-Nagel, Düren, Germany) according to the protocols from the manufacturer. Purity of the RNA was assessed using Nanodrop Spectrophotometer (ND-1000) (NanoDrop Technologies, Wilmington, DE, USA). RNA was stored at -80°C until use. The amount of 500 ng of total RNA was reverse transcribed using the GoScript Reverse Transcription System (Promega, Mannheim, Germany) following the protocols from the manufacturer and cDNA was stored at -20°C until use. Primers for the amplification of the target sequence were designed using Primer Express 3.0 (Applied Biosystems) and compared to the human genome database for unique binding using BLAST. The primer sequences and gene accession numbers used for the amplification of specific target sequences, which are beta-actin (ACTB), AAAS, CYP11A1, CYP17A1, CYP21A2, glutathione reductase (GSR), cytochrome P450 reductase (POR) and steroidogenic acute regulatory protein (StAR), are listed in the Supporting Information of this article (S1 Table).

The qPCR amplifications were performed in triplicates using the GoTaq Probe qPCR Master Mix (Promega) according to the manufacturer’s reaction parameters; using 20 μl total volumes on an ABI 7300 Fast Real-Time PCR System (Applied Biosystems, Life Technologies, Darmstadt, Germany). As housekeeping gene for normalisation ACTB was used. Positive controls contained a random mix of cDNA and negative controls contained nuclease-free water instead of cDNA. In all real-time qPCR experiments relative gene expression was calculated using the C_t method using standard and semi-log plots of amplification curves. Subsequently, the measured mRNA of each sample was firstly normalised to the gene expression relative of ACTB and secondly to a calibrator. In each case the calibrator was the native doxycycline-un-induced sample. Finally, results were expressed either in gene expression relative to ACTB or in percentile change in gene expression relative to ACTB and calibrator as follows: % change = (C_t sample/C_t calibrator) *100. In all results repeatability was assessed by standard deviation of triplicate C_ts and reproducibility was verified by normalising all real-time RT-PCR experiments by the C_t of each positive control per run.

The guidelines of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) were followed in this study to allow more reliable interpretation of real-time RT-PCR results [20–22].

Immunoblots

After induction with doxycycline for 48 h cells were lysed in 100 μl buffer containing 50 mM Tris (pH 7.4), 100 mM NaCl, 4% sodium dodecyl sulfate, and 1% Triton X-100. Protein concentration was measured using D_C Protein Assay (BioRad Laboratories, München, Germany) according to manufacturer’s instructions. In order to avoid high viscosity due to high DNA amount an additional step of benzonase nuclease (Novagen Merck Millipore, Darmstadt, Germany) treatment for 30 min at 37°C was done. Before loading 50 μg of protein per lane onto a NUPAGE Bis-Tris Mini Gel (Invitrogen, Life Technologies) samples were prepared with NUPAGE SDS Sample Buffer (4x), NUPAGE Reducing Agent (10x) and deionised water by heating the samples at 70°C for 10 min. After separation and electroblotting onto Amersham Hybond-enhanced chemiluminescence (ECL) nitrocellulose membranes (0.45 μm) (GE Healthcare, Braunschweig, Germany) non-specific binding of proteins to the membrane was blocked by incubation in PBS (Sigma-Aldrich) containing 3% bovine serum albumin (Sigma-Aldrich). The membrane was then probed with primary antibodies either ALADIN Antibody (B-11): sc-374073 (Santa Cruz Biotechnology, Inc., Heidelberg, Germany) (1:100 in 3% BSA) or monoclonal Anti-ß-Actin antibody produced in mouse, clone AC-74 (V1: NP_001092.1) (Sigma-Aldrich) (1:20000 in 3% BSA) over-night at 4°C. Membranes were washed with 0.01% Tween in PBS for 30 min and secondary antibodies goat anti-mouse IgG conjugated to horseradish peroxidase (1:2000 in 3% BSA) or goat anti-rabbit IgG conjugated to horseradish peroxidase (1:3000 in 5% milk powder) were incubated 1 h at room-temperature. Membranes were washed again for 30 min followed by detection using an Amersham ECL Prime Western Blotting detection system (GE Healthcare) using the protocol of the manufacturer. Blots were subsequently exposed to x-ray films and antigen bands visualised by autoradiography using Carestream Kodak autoradiography GPX replenisher/fixer (Kodak, Laborversand A. Hartenstein, Würzburg, Germany).

Chromatographic and mass spectrometric conditions and sample preparation

Steroids were isolated from 1 ml of cell culture supernatant by liquid/liquid extraction using 3 ml of methyl tertiary butyl ether (MTBE) (Sigma-Aldrich) in borosilicate glass tubes (Fisherbrand, Schwerte, Germany). Samples were vortexed twice for 5 seconds at highest speed, spinned down and subsequently frozen at -20°C for at least 1 h and the top organic layer was poured off into a new clean and dry glass tube. The frozen aqueous layer was discarded. Samples were evaporated for 15 min at 55°C and 0.5 bar using a nitrogen evaporator (Gebrüder Liebisch Labortechnik GmbH, Bielefeld, Germany). Samples were reconstituted in 50/50 methanol/water. They were analysed by tandem mass spectrometry on a Waters Xevo Mass Spectrometer with an acquity uPLC liquid chromatography system as described previously [23]. Steroids were separated using a HSS T3 1.2 x 50 mm column and identified in positive ionisation mode. System set-up is described in Supporting Information of this article (S2 Table). Steroids were quantified by comparison to a calibration series ranging from 0.5 to 1000 ng/ml and set off against total protein content (μg) per well, which represents the cell number. Steroid concentrations were expressed in mMol/g total protein content and each sample was normalised to its native doxycycline-un-induced state giving the percentile change in steroid output as follows: % change = (steroid concentration sample/steroid concentration native doxycycline-un-induced state) *100. All steroids were quantified using a suitable internal standard (S3 Table). A suit of steroids was considered covering the steroid bio-pathway; cortisol, cortisone, 11-deoxycortisol, corticosterone, androstenedione, testosterone, 5α-dihydrotestosterone (DHT), dehydroepiandrosterone (DHEA), 17-hydroxyprogesterone (17OHP), deoxycorticosterone (DOC), progesterone, pregnenolone, and 17-hydroxypregnenolone. Two mass transitions were required to positively quantify each steroid.

Cell Viability Assay

For measurement of cell viability, stably transfected cells were sub-cultured at a density of 10⁴ cells/well onto 96-well culture dishes (Corning Costar). After 24 h medium was added containing doxycycline. After another 48 h one part of the cells was exposed to oxidative stress with 0.2 mM paraquat. Cell viability was measured in triplicate in paraquat treated and untreated cells using CellTiter-Blue Cell Viability Assay (Promega) according to the manufacturer’s protocol in a final volume of 120 μl. Fluorescence emission at 590 nm of resorufin was measured after 4 h using the Infinite 200 PRO Microplate Reader and the Magellan Data Analysis Software v6.6 (Tecan Group AG, Männedorf, Switzerland). Experiments were repeated at least six times.

Measurement of total and oxidised glutathione

For measurement of total glutathione (GSH) and its oxidised form (GSSG), stably transfected cells were sub-cultured at a density of 10⁴ cells/well onto white-walled and white-bottomed 96-well culture dishes (Corning Costar). After 24 h medium was added containing doxycycline. After another 48 h cells were exposed to oxidative stress as described above. Total GSH and GSSG were measured in triplicate using GSH/GSSG-Glo Assay (Promega) and the protocol recommended by the manufacturer. Luminescence was recorded after 15 min using the Mithras LB940 luminometer and the MikroWin 2000 software v4.29 (Berthold Technologies, Bad Wildbad, Germany). An integration time of 0.5 sec for each 96-well-micro plate was used. Experiments were repeated at least five times.

Hydrogen Peroxide Assay

To detect H₂O₂ released from and within cells, stably transfected cells were sub-cultured at a density of 10⁴ cells/well onto 96-well culture dishes (Corning Costar). After 24 h medium was added containing doxycycline. After another 48 h the cells were exposed to oxidative stress with 0.2 mM paraquat. The concentration of H₂O₂ was measured in triplicate in paraquat treated and untreated cells using Amplex Red Hydrogen Peroxide Assay (Invitrogen) according to the manufacturer’s protocol in a final volume of 100 μl. Amplex Red reagent reacts with H₂O₂ and produces the red-fluorescent oxidation product resorufin. Fluorescence emission at 590 nm of resorufin was measured after 5 h using the Infinite 200 PRO Microplate Reader and the Magellan Data Analysis Software v6.6 (Tecan Group AG, Männedorf, Switzerland). Experiments were repeated at least four times.

Nuclear import processes and microscopy

Transient transfected cells grown on cover slips were washed twice with PBS, fixed with 4% PFA in PBS (Sigma-Aldrich) for 10 min, washed again with PBS and mounted onto 3x1 inch microscope slides (Engelbrecht, Edermünde, Germany) with Vectashield mounting medium for fluorescence without DAPI (Vector Laboratories, Burlingame, CA, USA). For oxidative stress treatment cells were induced for another 24 h with 0.2 mM paraquat before fixation. Fluorescence was recorded using Axiovert 200 M (Carl Zeiss) and pictures taken using x40 objective, Axiocam MRm (Carl Zeiss) and filter set 38HE (excitation BP470/40, beam splitter FT 495, emission BP 525/50). Bright-field and fluorescence pictures were analysed using Fuji v1.48b (Fuji Is Just ImageJ). All input pictures were grey-scaled with auto exposure time for each picture. Cell cytosols and nuclei were analysed semi-automatically. Briefly, each cell cytosol was measured automatically using the auto-threshold feature of ImageJ (Method Triangle) and the subsequent nucleus was marked manually. Region of interests (ROIs) of cytosols and nuclei were extracted on basis of the bright-field picture. These ROIs were transferred to the fluorescence picture and measured, giving the following data values: for fluorescence intensity of cytosol and nucleus each; mean, median, minimum, maximum, area, standard deviation, percentage distribution, ratio (mean_nuc/mean_cyt) and for the nuclei, nucleus numbering (in order to verify and double-check the automatic process). Output values for fluorescence intensity of cytosols and nuclei ranged from 0 to 255; consequently, 0 resembles no fluorescence intensity and 255 maximum fluorescence intensity. Ratios mean_nuc/mean_cyt were plotted in order to ascertain potential import impairment. Experiments were repeated twice.

Statistics

Statistical analyses were made using the open-source-software R i386 v2.15.0 and R Studio version v0.98.1074 (The R Foundation for Statistical Computing, Vienna, Austria). All values were expressed as a mean ± standard deviation. As assumption of normality (“goodness-of-fit”) the following tests were conducted: Shapiro-Wilk-test and Q-Q-Plot. Unpaired and paired Student’s t-tests were used. During evaluation of the results a confidence interval alpha of 95% and P values lower than 0.05 were considered as statistically significant. Results are shown as box plots which give a fast and efficient overview about median, first and third quartile (25^th and 75^th percentile, respectively), interquartile range (IQR), minimal and maximal values and outliers. Box plots give an intuitive first impression of position and statistical spread of the measurement.

Results

Establishment of two different ALADIN expression models

Down-regulation and over-expression of AAAS was confirmed on mRNA level (n = 6; n gives the minimum number of independent experiments) and on the protein level by Western blot (Fig 1) (n = 6). The establishment of stable doxcycline-inducible ALADIN knock-down and over-expression sub-clones of the adrenocortical cell line NCI-H295R1 was successful.

Download:

Fig 1. Down-regulation and over-expression of AAAS on mRNA and protein level.

Knock-down and over-expression in stably transfected NCI-H295R1-TR cells was induced by treatment with doxycycline for 48 h: (A-B) Boxplots of down-regulation and over-expression of AAAS on mRNA level (TaqMan analysis) and (C-D) evidence of down-regulation and over-expression of AAAS on protein level (Western blot). Scr, scrambled shRNA. KD, knock-down. EV, empty vector (= pcDNA4/TO). OE, over-expression. Native, without doxycycline induction. Dox, doxycycline induction. n, minimum number of independent experiments. P-values: * P<0.05, ** P<0.01, *** P<0.001. Significant differences were measured with paired and unpaired Student’s t-Test. Boxplot widths are proportional to the square root of the samples sizes. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots.

https://doi.org/10.1371/journal.pone.0124582.g001

Without doxycycline stimulation we observed a partial AAAS knock-down and over-expression when compared to the subsequent controls (Fig 1). Many of the positive results shown in the article were based on the doxycycline un-induced cells and it had to be assumed that the TREx system used as method of choice appeared to be leaky. The repressor-expressing plasmid pcDNA6TR seemed to be out-numbered in each cell model by the inducible expression vectors pTER for shRNA silencing and pcDNA4/TO for hAAAS cDNA over-expression which both contain the tetracycline-response element. In the doxycycline un-induced state the amount of repressor produced seemed not to be enough in order to block expression of shRNA or hAAAS cDNA leading to the partial AAAS knock-down and over-expression described here.

Deprivation of ALADIN leads to impairment of glucocorticoid and androgenic steroidogenesis and cytochrome P450 oxidoreductase

To investigate the effects of AAAS knock-down and over-expression on steroidogenesis we assessed mRNA expression of key enzymes involved in steroidogenesis including CYP11A1, CYP11B1, CYP17A1, CYP21A2, 24-dehydrocholesterol reductase (DHCR24), cytochrome P450 oxidoreductase (POR) and StAR. We further measured steroid production employing LC/MS-MS in NCI-H295R1 AAAS knock-down and AAAS over-expression cells. With quantitative RT-PCR we revealed that AAAS knock-down induced a significant down-regulation of the genes coding for enzymes involved in the glucocorticoid and androgenic pathways, i.e. 17α-hydroxylase/17,20lyase (CYP17A1) and 21-hydroxylase (CYP21A2) (n = 6) (Fig 2). Expression of StAR, CYP11A1, CYP11B1 and DHCR24 was not affected in these cells (S1 and S2 Figs). Similar effects were seen in the functional steroid output of the cells measured by LC/MS-MS. Changes in steroid production were predominantly observed for 17OHP, 11-deoxycortisol (compound S) and androstenedione, whereas only minor changes in the remaining 10 steroids were observed. Thus, for simplification, the following results focus on those three steroids. We revealed that ALADIN knock-down cells show a significant decrease in precursor metabolites required in the glucocorticoid and androgenic pathways. These precursors are 17OHP, 11-deoxycortisol and androstenedione (n = 6) (Fig 2). There was no change in precursor metabolites of the mineralocorticoid pathway (DOC) (S3 Fig). Furthermore we show that the ALADIN-dependent impairment of the glucocorticoid and androgenic pathways is accompanied by a down-regulation of the gene coding for POR, an enzyme managing electron transfer from NADPH to CYP17A1 and CYP21A2 microsomal P450 hydroxylases (Fig 2). A decrease in POR gene expression was observed in knock-down cells prior to doxycycline treatment, most likely representing the partial AAAS knock-down shown in Fig 1.

Download:

Fig 2. TaqMan analysis and LC/MS-MS of stably transfected NCI-H295R1-TR AAAS knock-down cells.

Cells were induced by 48 h treatment with doxycycline. Scr, scrambled shRNA. KD, knock-down. 17OHP, 17-hydroxyprogesterone. A’dione, androstenedione. Compound S, 11-deoxycortisol. n, minimum number of independent experiments. P-values: * P<0.05, ** P<0.01, *** P<0.001. Significant differences were measured with paired and unpaired Student’s t-Test. Boxplot widths are proportional to the square root of the samples sizes. Hundred percent boxes for native scrambled shRNA and knock-down are not shown. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots.

https://doi.org/10.1371/journal.pone.0124582.g002

AAAS over-expression in at least four triplicate experiments did not result in significant differences in expression of key enzymes involved in steroidogenesis and also did not impact on steroid production (S1, S2 and S3 Figs, respectively).

The redox homeostasis of the cell is altered by ALADIN knock-down under exogenous oxidative stress

We investigated cell viability in both the AAAS knock-down and over-expression models. To determine the role of ALADIN in redox homeostasis, we ascertained how AAAS knock-down and over-expression affect the ratio between GSH and GSSG. When cells are exposed to increased levels of oxidative stress, NADPH decreases and GSSG accumulates. Consequently, the GSH/GSSG ratio decreases which is a good indicator for cellular oxidative stress. NADPH is used by glutathione reductase (GSR) to generate the anti-oxidant GSH from its oxidised form GSSG. GSR gene expression was measured in both AAAS expression models in order to verify a GSR-dependent redox pathway disturbance leading to accumulation of GSSG.

Cell viability with and without exogenous oxidative stress

In NCI-H295R1-TR AAAS knock-down cells exposed to paraquat for 24 h (n = 7) we observed a significant decrease in cell viability with oxidative stress compared to treated control cells (Fig 3). Viability was not decreased after doxycycline treatment in scrambled shRNA-transfected cells. However, a decrease was observed in knock-down cells prior to doxycycline treatment, most likely representing the partial AAAS knock-down shown in Fig 1. The fully induced AAAS knock-down did not lead to a further decrease in cell viability after paraquat. Cell viability without oxidative stress was not significantly altered.

Download:

Fig 3. Boxplots of the analysis of (A-B) cell viability, (C-D) glutathione ratios and (E-F) hydrogen peroxide production under oxidative stress.

ALADIN knock-down and over-expression in stably transfected NCI-H295R1-TR was induced by 48 h treatment with doxycycline and cells were additionally treated with 0.2 mM paraquat for 24 h. Em, fluorescence emission at 590 nm. GSH, reduced glutathione. GSSG, oxidised disulphide glutathione. H₂O₂, hydrogen peroxide. Scr, scrambled shRNA. KD, knock-down. EV, empty vector (= pcDNA4/TO). OE, over-expression. Native, without doxycycline induction. Dox, doxycycline induction. n, minimum number of independent experiments. P-values: * P<0.05. Significant differences were measured with unpaired Student’s t-Test. Boxplot widths are proportional to the square root of the samples sizes. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots.

https://doi.org/10.1371/journal.pone.0124582.g003

Surprisingly, in AAAS over-expressing cells we observed similar effects after paraquat treatment (n = 6) (Fig 3). Viability was not altered after doxycycline induction in the control cells carrying the empty vector. However, cell viability was already significantly decreased after paraquat treatment in the native over-expression cells without the induction of doxycycline representing a partial AAAS over-expression (Fig 1). The fully induced over-expression cells did not show further alteration in viability after treatment with paraquat. Cell viability without oxidative stress did not show any significant change.

GSH/GSSG ratio with exogenous oxidative stress

In Fig 3 we demonstrate that GSH/GSSG ratios were markedly decreased in NCI-H295R1-TR AAAS knock-down and over-expression cells after paraquat treatment for 24 h compared to treated control cells (n = 5). However, in cells with the partial AAAS knock-down and over-expression without induction of doxycycline GSH/GSSG ratios were already significantly down-regulated and no further impairment after doxycycline induction could be observed.

Hydrogen peroxide production with exogenous oxidative stress

In order to give further evidence that ALADIN is involved in the oxidative stress response of the cell we measured hydrogen peroxide (H₂O₂) production in stably transfected cells after exposure to oxidative stress. We presumed that after oxidative stress treatment the oxidants NADPH and GSH will decrease leading to a rise of H₂O₂. Cells showing an impaired oxidative response concomitantly suffer from an increased ROS level and cellular damage.

Consistent with the results of cell viability analysis and GSH/GSSG ratio in NCI-H295R1-TR AAAS knock-down cells after paraquat treatment we observed a significantly increased level of H₂O₂ concentration in these cells compared to paraquat-treated control scrambled shRNA-cells (n = 4) (Fig 3). After doxycycline induction in NCI-H295R1-TR AAAS knock-down cells no further significant increase of H₂O₂ concentration could be observed; the partial knock-down without induction of doxycycline (Fig 1) is enough to disturb the oxidative response of the cell.

In AAAS over-expressing cells with or without doxycycline induction we could not demonstrate significant changes in H₂O₂ concentration after paraquat treatment compared to control cells carrying the empty vector (n = 5) (Fig 3).

Gene expression of glutathione reductase

Analysis of the gene expression level of glutathione reductase (GSR) demonstrated that in NCI-H295R1-TR AAAS knock-down cells there was no significant change in expression level compared to scrambled-shRNA control cells with or without doxycycline (n = 4) (Fig 4).

Download:

Fig 4. Box plots of TaqMan analysis of glutathione reductase.

Stably transfected NCI-H295R1-TR AAAS knock-down cells and over-expression were induced by 48 h treatment with doxycycline. GSR, glutathione reductase. Scr, scrambled shRNA. KD, knock-down. EV, empty vector (= pcDNA4/TO). OE, over-expression. Native, without doxycycline induction. Dox, doxycycline induction. n, minimum number of independent experiments. P-values: *** P<0.001. Significant differences were measured with unpaired Student’s t-Test. Boxplot widths are proportional to the square root of the samples sizes. Hundred percent boxes for native scrambled shRNA and knock-down are not shown. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots.

https://doi.org/10.1371/journal.pone.0124582.g004

In contrast GSR expression level in NCI-H295R1-TR AAAS over-expression cells without induction of doxycycline was significantly reduced compared to control cells carrying the empty vector used for the over-expression vector construct (n = 4) (Fig 4). Induction with doxycycline in AAAS over-expression cells increases the GSR expression level but the increase was not statistically significant.

Overall, we demonstrate that under exogenous oxidative stress using paraquat the redox response of the cell after AAAS knock-down in NCI-H295R1-TR is significantly impaired and leads to accumulation of hydrogen peroxide. The expression of GSR was not affected in AAAS knock-down cells under basal conditions, implying a normal prerequisite of antioxidant defence at GSR expression level when applying paraquat. AAAS over-expression cells suffer from decreased viability and glutathione levels under oxidative stress. In these cells the expression of GSR was reduced under basal conditions implying an increase of sensitivity during exogenous oxidative stress.

The nuclear import of aprataxin, DNA ligase 1 and ferritin heavy chain 1 is disturbed by ALADIN

Using both the human adrenal NCI-H295R1-TR AAAS knock-down and over-expression models we investigated the potential impairment of the nuclear import of aprataxin, DNA ligase 1 and ferritin heavy chain 1 employing YFP-specific vectors transiently transfected into the cell lines.

Nuclear import in AAAS knock-down cells

The nuclear import of aprataxin, DNA ligase 1 and ferritin heavy chain 1 was markedly impaired after ALADIN deprivation (n = 26, n = 83 and n = 51, respectively; n gives the minimum number of analysed cells per cell type) (Figs 5 and 6). Nevertheless, nuclear import was not changed after doxycycline treatment but already in the native state without doxycycline induction probably reflecting a partial AAAS knock-down. The induced AAAS knock-down did not lead to a further decrease of nuclear import of aprataxin, DNA ligase 1 and ferritin heavy chain 1 compared to the native state without doxycycline induction (Fig 5). Upon treatment with paraquat for 24 h we found a significant increase in nuclear import of ferritin heavy chain 1 in scrambled-shRNA control cells and AAAS knock-down cells but there was no significant difference between those two groups (n = 26) (Fig 7).

Download:

Fig 5. Analysis of fluorescent microscopy of the nuclear import of aprataxin, DNA ligase 1 and ferritin heavy chain 1.

Knock-down and over-expression in stably transfected NCI-H295R1-TR AAAS knock-down and over-expression cells was induced by 48 h treatment with doxycycline. Scr, scrambled shRNA. KD, knock-down. EV, empty vector (= pcDNA4/TO). OE, over-expression. Native, without doxycycline induction. Dox, doxycycline induction. n, minimum number of analysed cells per cell type. P-values: * P<0.05, ** P<0.01, *** P<0.001. Significant differences were measured with unpaired Student’s t-Test. Boxplot widths are proportional to the square root of the samples sizes. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots. The experiment was repeated twice.

https://doi.org/10.1371/journal.pone.0124582.g005

Download:

Fig 6. Nuclear import of ferritin heavy chain 1-tagged YFP.

Results of fluorescent microscopy of transiently transfected stable NCI-H295R1-TR scrambled shRNA and AAAS knock-down cells. Knock-down in stably transfected NCI-H295R1-TR AAAS knock-down cells was induced by 48 h treatment with doxycycline. Scr, scrambled shRNA. KD, knock-down. Dox, doxycycline induction.

https://doi.org/10.1371/journal.pone.0124582.g006

Download:

Fig 7. Fluorescent microscopy of the nuclear import of ferritin heavy chain 1 after treatment with paraquat.

Knock-down and over-expression in stably transfected NCI-H295R1-TR AAAS knock-down and over-expression cells was induced by 48 h treatment with doxycycline. Scr, scrambled shRNA. KD, knock-down. EV, empty vector (= pcDNA4/TO). OE, over-expression. Native, without paraquat treatment. PQ, paraquat treatment. n, minimum number of analysed cells per cell type. P-values: * P<0.05, *** P<0.001. Significant differences were measured with unpaired Student’s t-Test. Boxplot widths are proportional to the square root of the samples sizes. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots. The experiment was repeated twice.

https://doi.org/10.1371/journal.pone.0124582.g007

Nuclear import in AAAS over-expression cells

Cells over-expressing ALADIN did not show any change in nuclear import of aprataxin and DNA ligase 1 (n = 55 and n = 50, respectively) (S4 Fig). Interestingly, the import of ferritin heavy chain 1 was markedly impaired (n = 22) (Fig 5). The nuclear import of FTH1 was already impaired in the doxycycline-un-induced AAAS over-expressing cells and no further impairment could be observed after doxycycline induction. When treating control cells carrying the empty over-expression vector and AAAS over-expression cells with 0.2 mM paraquat for 24 h FTH1 was significantly imported into the nucleus (n = 172) (Fig 7). There was a significant difference in FTH import after paraquat treatment between control and over-expressing cells.

Discussion

We investigated the cellular role of ALADIN by creating two experimental expression systems using the human adrenocortical carcinoma cell line NCI-H295R1-TR that resembles the glucocorticoid producing adrenal zona fasciculata [16]. These cells were successfully transformed to either over-express or down-regulate ALADIN by a doxycycline-inducible stable expression of either AAAS-shRNA (AAAS down-regulation) or AAAS-mRNA (AAAS over-expression). In this study we successfully demonstrate that AAAS knock-down firstly induces a significant down-regulation of genes coding for type II microsomal CYP enzymes involved in the glucocorticoid and androgen pathways of steroidogenesis, CYP17A1 and CYP21A2, and of the gene coding for their electron donor enzyme POR. Secondly, we revealed that the functional output of these enzymes, i.e. precursor metabolites of the glucocorticoid and androgen pathways, was markedly decreased in ALADIN knock-down cells. In triple A patients adrenal insufficiency may appear later in life than the other two symptoms and its development is gradually [24]. Glucocorticoid and androgen production is affected, consistent with our results in-vitro where production of precursors involved in these pathways (17OHP, 11-deoxycortisol and androstenedione) was impaired. 15% of patients however show a deficiency in mineralocorticoid production [25,28]. Precursor metabolites of the mineralocorticoid pathway (DOC) were not impaired in our experiments. Mitochondrial aldosterone synthase encoded by CYP11B2 exhibits 11ß-hydroxylase activity beside its activity to catalyse aldosterone from corticosterone by 18-hydroxylation. 11ß-hydroxylase activity is expressed by a closely related mitochondrial enzyme CYP11B1 in order to produce cortisol from 11-deoxycortisol [26]. Furthermore it was shown that CYP11B2 exhibits some activity to hydroxylate 11-deoxycortisol [26,27]. Thus, it can be assumed that 11-deoxycortisol can serve as a substrate for aldosterone production. The relative preservation of mineralocorticoid production in triple A patients resembles the lower production of aldosterone compared to cortisol. This may save the zona glomerulosa from cell degeneration as it is seen for the other zones [28].

Even though Prasad et al. already provided some evidence that lentivirally transduced ALADIN-deficient adrenal cells show an alteration in steroidogenesis due to a decrease of expression of steroidogenic acute regulatory protein (StAR) and P450c11ß (CYP11B1) [12], we employed stable transfection for AAAS knock-down (and over-expression) and comprehensively investigated the effects on steroidogenic enzyme expression and steroid production. By using tandem mass spectrometry for multiple steroid identification and quantitation in this study we are able to provide strong evidence for a significant functional impairment of the glucocorticoid and androgenic pathways in ALADIN-deficient cells. Our findings has led us a step further to the exact mechanism how ALADIN deficiency affects steroidogenesis and elucidates more details about the pathogenicity in Triple A syndrome. These results therefore significantly add to our understanding of the role of ALADIN for adrenal steroidogenesis. Many of the results are demonstrated in the partial AAAS knock-down state, i.e. the doxycycline un-induced state in which too little repressor is produced to efficiently block AAAS shRNA expression leading to a premature AAAS knock-down. Nevertheless, the amount of AAAS shRNA produced is enough to silence AAAS gene expression and to exert a pathogenic phenotype in the adrenal cells. Adenoviral transduction in primary bovine adrenocortical cells has been shown to lead to impairment of steroidogenesis and alteration of cell morphology [29]. In regard to human adrenocortical cells Matkovic et al. could show that adenoviral infection leads to alteration in steroidogenesis, presumably not due to viral transgene expression but rather due to viral structure encounter [30]. We therefore assume that the discrepancies in the findings between Prasad et al. and our study lie primarily in the alternative cell model (transduction and stable transfection) and to some extent in the experimental sample sizes especially for steroid analyses. Additionally, the zona fasciculata sub-strain 1 of NCI-H295R cells [16] which resembles one of the zones most degenerated in triple A patients [28] is different from the cells used by Prasad and colleagues.

In our study we also ascertained that after AAAS knock-down in NCI-H295R1-TR cells not only cellular NADPH levels and GSH/GSSG levels under oxidative stress using paraquat are significantly decreased, but also that the concentration of cellular hydrogen peroxide (H₂O₂) is increased. Glutathione reductase (GSR) expression was not altered under basal conditions suggesting that the increase in sensitivity to oxidative stress in these cells was not the result of low GSR expression. These findings imply that ALADIN knock-down cells have an altered redox homeostasis and, hence, are more sensitive to oxidative stress (Fig 8). In order to further address the involvement of ALADIN in the oxidative stress response we studied the impairment of the nuclear import of proteins that protect the nucleus against reactive oxygen species (ROS). The nuclear import of aprataxin, DNA ligase 1 and ferritin heavy chain 1 was markedly decreased after ALADIN depletion. We can therefore conclude that as previously shown in fibroblast cells deriving from triple A syndrome patients [11,14,15] ALADIN is involved in oxidative stress responses and import of these proteins also in adrenal tissue. In addition, we previously observed that fibroblast cells of triple A patients show an altered down-regulation or induction of genes associated with oxidative stress and antioxidant defence [13]. Aprataxin and DNA ligases work concomitantly together in order to initiate and repair DNA in multiple pathways and upon multiple damages, especially ROS-mediated damage [31]. Furthermore it has previously been shown that neurological disorders caused by mutations in the gene APTX coding for aprataxin are probably caused by accumulation of unrepaired DNA strand breaks resulting from abortive DNA ligation, generated especially by oxidation [31,32]. Another possibility of abortive DNA ligation (including DNA ligase 1) is during ribonucleotide excision repair. It has been shown that adenylated RNA-DNA lesions are resolved by aprataxin and that accumulation of these lesions is associated with neurologic diseases [33]. Triple A syndrome is commonly associated with a variety of neurologic impairments, presumably due to an increasing number of RNA-DNA lesions in patients’ neurons. Aprataxin and DNA ligase 1 both contain a nuclear localisation signal and are thought to be translocated into the nucleus by a karyopherin-α/β-mediated pathway through NPCs. Hirano et al. showed that nuclear import of aprataxin and DNA ligase 1 is impaired when treating patient fibroblasts and control cells with L-buthionine-(S,R)-sulfoximine (BSO), a glutathione-depleting agent, but single-stranded DNA breaks increased only in patient cells [15]. Increased oxidative stress by BSO seems to intensify nuclear import impairment in patient fibroblasts seen by accumulation of single-stranded DNA breaks. These findings in patient fibroblasts are now confirmed by our results in ALADIN knock-down adrenal cells which are also depleted of reduced glutathione and show impaired nuclear import of aprataxin and DNA ligase 1.

Download:

Fig 8. Increase of cellular susceptibility to oxidative stress after AAAS knock-down in NCI-H295R1-TR.

GSH, reduced glutathione. GSSG, oxidised glutathione disulphide. GPX, glutathione peroxidase. GSR, glutathione reductase. H₂O₂, hydrogen peroxide.

https://doi.org/10.1371/journal.pone.0124582.g008

In AAAS over-expressing cells, neither steroidogenic enzyme expression nor steroid production was altered. Surprisingly, similar to ALADIN deprivation, over-expressing cells showed a significant impairment of cell viability and GSH/GSSG ratio under oxidative stress but cellular H₂O₂ concentration was not increased. In addition we found that over-expressing cells have a decreased expression of GSR which explains the decreased GSH/GSSG ratio. These results suggest that AAAS over-expression cells do not have an impaired redox potential and are able to detoxify an increased level of ROS after paraquat treatment compared to AAAS knock-down cells. In addition, it explains the finding that AAAS over-expression cells do not show an alteration in steroidogenesis but rather behave like control cells. The impaired cell viability and decreased expression of GSR may be caused by cell stress due to an increased ALADIN protein synthesis and significant accumulation in the cytosol and ER. Cellular ER stress has been recently reported to cause increased protein folding-stress. Initial protein maturation takes place at the ER and is of high importance of proper protein folding. Increased protein synthesis and folding, especially in specialised secretory cells, introduces a high level of stress and a particular challenge for the cell. If the ER machinery is working over-strained an excess of synthesised proteins will be sensed causing a stop of translation, ultimately leading to cell death [34]. We hypothesise that this phenomenon accounts for our AAAS over-expressing cells.

AAAS over-expressing cells did not show any change in nuclear import of aprataxin or DNA ligase 1. In addition, the import of ferritin heavy chain 1 was significantly decreased after AAAS over-expression. These results together with the ALADIN knock-down results confirm our previously reported finding that ALADIN interacts with and is involved in the nuclear import of ferritin heavy chain 1 [14]. Ferritin heavy chain 1 is an iron chelator and its intrinsic ferroxidase activity is an important player in the cellular antioxidant defence system by converting ferrous iron to its ferric storage form which can act in the Fenton reaction as a ROS scavenger. In addition, FTH1 is shown to have transcriptional regulatory activity which explains its translocation to the nucleus besides protecting the DNA from ROS. Regarding its nuclear import it is known that FTH1 enters the nucleus through NPCs but no obvious nuclear localisation signal has been found so far. It is rather thought to be shuttled by a chaperon molecule to the NPC and into the nucleus [35–37]. In corneal epithelial cells it was shown that FTH1 not passively diffuses into the nucleus but is rather shuttling by a chaperon molecule, called ferritoid. But this molecule seems to be highly specific for this cell type [38,39]. In this study that we demonstrate that AAAS over-expression leads to a significant accumulation of ALADIN in the cytoplasm; most likely due to a lack of binding sites of ALADIN at the pore complexes. Consequently, mis-localisation of ALADIN in the cytoplasm leads to a decrease of nuclear import and subsequent retention of ferritin heavy chain 1 in the cytoplasm. After treating ALADIN knock-down and over-expression cells with paraquat for 24 h we observed an increase of nuclear import of FTH1. However, this import was significant diminished in the over-expression model in comparison to paraquat treated control cells. In the knock-down model this effect was not obvious, probably due to an insufficient total loss of ALADIN at the nuclear pore. Thus, we show here that ferritin heavy chain 1 is withheld in the cytoplasm by ALADIN in the over-expression cells. It still remains to be clarified how FTH1 is translocated into the nucleus and how this protein interacts with ALADIN.

In conclusion, the results of the knock-down experiments in the human cell line NCI-H295R1 are in accordance with the pathology in triple A syndrome patients showing an alteration in adrenal steroidogenesis, especially the glucocorticoid and androgenic pathways, and an impairment in the cellular response to oxidative stress. No such adrenal phenotype has so far been shown in Aaas^-/- mice which predominantly have a zona glomerulosa [40]. Our findings suggest that alteration in adrenal steroidogenesis in humans through POR is caused by a defective redox potential and homeostasis due to ALADIN deficiency. The presence of ALADIN seems to be of high significance for detoxification of ROS in adrenocortical cells and puts weight on the genuine susceptibility of this organ to oxidative stress. Our results demonstrate that these processes especially affect adrenal cells and are likely to be causally linked to the adrenal phenotype in triple A syndrome. Further studies are needed to clarify how the ALADIN-mediated changes in steroidogenesis are coupled to the mitochondrial oxidative stress response and the nuclear import of proteins protecting cells against increased ROS.

Supporting Information

S1 Fig. Boxplots of the results of TaqMan analysis.

(A-B) StAR and CYP11A1 of AAAS knock-down and over-expression cells, (C) CYP17A1 and CYP21A2 and (D) POR of AAAS over-expression cells. Knock-down and over-expression in stably transfected NCI-H295R1-TR cells was induced by 48 h treatment with doxycycline. Scr, scrambled shRNA. KD, knock-down. EV, empty vector (= pcDNA4/TO). OE, over-expression. Native, without doxycycline induction. Dox, doxycyline induction. n, number of independent experiments. Boxplot widths are proportional to the square root of the samples sizes. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots.

https://doi.org/10.1371/journal.pone.0124582.s001

(TIF)

S2 Fig. Boxplots of the results of quantitative real-time PCR.

(A-B) DHCR24 and (C-D) CYP11B1 of AAAS knock-down and over-expression cells. Knock-down and over-expression in stably transfected NCI-H295R1-TR cells was induced by 48 h treatment with doxycycline. Scr, scrambled shRNA. KD, knock-down. EV, empty vector (= pcDNA4/TO). OE, over-expression. Native, without doxycycline induction. Dox, doxycyline induction. n, number of independent experiments. Boxplot widths are proportional to the square root of the samples sizes. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots.

https://doi.org/10.1371/journal.pone.0124582.s002

(TIF)

S3 Fig. Boxplots of the results of LC/MS-MS.

(A) DOC of stably transfected NCI-H295R1-TR AAAS knock-down and over-expression cells and (B) 17OHP, a’dione and compound S of AAAS over-expression cells. Induction with doxycycline was done for 48 h. Scr, scrambled shRNA. KD, knock-down. EV, empty vector (= pcDNA4/TO). OE, over-expression. DOC, deoxycorticosterone. 17OHP, 17-hydroxyprogesterone. A’dione, androstenedione. Compound S, 11-deoxycortisol. n, number of independent experiments. Boxplot widths are proportional to the square root of the samples sizes. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots.

https://doi.org/10.1371/journal.pone.0124582.s003

(TIF)

S4 Fig. Analysis of fluorescent microscopy of stably transfected NCI-H295R1-TR AAAS over-expression cells.

Nuclear import of (A) aprataxin and (B) DNA ligase 1. Induction with doxycycline was done for 48 h treatment. EV, empty vector (= pcDNA4/TO). OE, over-expression. Native, without doxycycline induction. Dox, doxycycline induction. n, minimum number of analysed cells per cell type. Boxplot widths are proportional to the square root of the samples sizes. Whiskers indicate the range outside 1.5 times the inter-quartile range (IQR) above the upper quartile and below the lower quartile. Outliers were plotted as dots. The experiment was repeated twice.

https://doi.org/10.1371/journal.pone.0124582.s004

(TIF)

S1 Protocol. Quantitative real-time PCR using a double-stranded DNA-binding dye as reporter.

https://doi.org/10.1371/journal.pone.0124582.s005

(DOC)

S1 Table. Real-time qPCR primer sequences.

https://doi.org/10.1371/journal.pone.0124582.s006

(DOC)

S2 Table. LC/MS system parameters.

https://doi.org/10.1371/journal.pone.0124582.s007

(DOC)

S3 Table. Mass transitions and retention times of steroids.

Steroids in italic represent internal standards.

https://doi.org/10.1371/journal.pone.0124582.s008

(DOC)

Acknowledgments

We are grateful to Enzo Lalli for providing the inducible siRNA expression vector pTER and the NCI-H295R1-TR cell line. We thank Dana Landgraf for excellent technical assistance.

Author Contributions

Conceived and designed the experiments: RJ JI AET WA AH KK. Performed the experiments: RJ AET. Analyzed the data: RJ JI AET WA AH KK. Contributed reagents/materials/analysis tools: RJ JI AET BK WA AH KK. Wrote the paper: RJ AET WA AH KK.

References

1. Allgrove J, Clayden GS, Grant DB, Macaulay JC. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1978 Jun 17;1(8077):1284–1286. pmid:78049
- View Article
- PubMed/NCBI
- Google Scholar
2. Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, et al. Mutant WD-repeat protein in triple-A syndrome. Nat Genet 2000 Nov;26(3):332–335. pmid:11062474
- View Article
- PubMed/NCBI
- Google Scholar
3. Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet 2001 Feb 1;10(3):283–290. pmid:11159947
- View Article
- PubMed/NCBI
- Google Scholar
4. Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002 Sep 2;158(5):915–927. pmid:12196509
- View Article
- PubMed/NCBI
- Google Scholar
5. Cronshaw JM, Matunis MJ. The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Proc Natl Acad Sci U S A 2003 May 13;100(10):5823–5827. pmid:12730363
- View Article
- PubMed/NCBI
- Google Scholar
6. Krumbholz M, Koehler K, Huebner A. Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome—shedding light on an unexpected splice mutation. Biochem Cell Biol 2006 Apr;84(2):243–249. pmid:16609705
- View Article
- PubMed/NCBI
- Google Scholar
7. Koehler K, Brockmann K, Krumbholz M, Kind B, Bonnemann C, Gartner J, et al. Axonal neuropathy with unusual pattern of amyotrophy and alacrima associated with a novel AAAS mutation p.Leu430Phe. Eur J Hum Genet 2008 Dec;16(12):1499–1506. pmid:18628786
- View Article
- PubMed/NCBI
- Google Scholar
8. Kind B, Koehler K, Lorenz M, Huebner A. The nuclear pore complex protein ALADIN is anchored via NDC1 but not via POM121 and GP210 in the nuclear envelope. Biochem Biophys Res Commun 2009 Dec 11;390(2):205–210. pmid:19782045
- View Article
- PubMed/NCBI
- Google Scholar
9. Yamazumi Y, Kamiya A, Nishida A, Nishihara A, Iemura S, Natsume T, et al. The transmembrane nucleoporin NDC1 is required for targeting of ALADIN to nuclear pore complexes. Biochem Biophys Res Commun 2009 Nov 6;389(1):100–104. pmid:19703420
- View Article
- PubMed/NCBI
- Google Scholar
10. Rabut G, Doye V, Ellenberg J. Mapping the dynamic organization of the nuclear pore complex inside single living cells. Nat Cell Biol 2004 Nov;6(11):1114–1121. pmid:15502822
- View Article
- PubMed/NCBI
- Google Scholar
11. Kind B, Koehler K, Krumbholz M, Landgraf D, Huebner A. Intracellular ROS level is increased in fibroblasts of triple A syndrome patients. J Mol Med (Berl) 2010 Dec;88(12):1233–1242. pmid:20706703
- View Article
- PubMed/NCBI
- Google Scholar
12. Prasad R, Metherell LA, Clark AJ, Storr HL. Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Endocrinology 2013 Sep;154(9):3209–3218. pmid:23825130
- View Article
- PubMed/NCBI
- Google Scholar
13. Koehler K, End K, Kind B, Landgraf D, Mitzscherling P, Huebner A. Changes in differential gene expression in fibroblast cells from patients with triple A syndrome under oxidative stress. Horm Metab Res 2013 Feb;45(2):102–108. pmid:23315990
- View Article
- PubMed/NCBI
- Google Scholar
14. Storr HL, Kind B, Parfitt DA, Chapple JP, Lorenz M, Koehler K, et al. Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol Endocrinol 2009 Dec;23(12):2086–2094. pmid:19855093
- View Article
- PubMed/NCBI
- Google Scholar
15. Hirano M, Furiya Y, Asai H, Yasui A, Ueno S. ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Proc Natl Acad Sci U S A 2006 Feb 14;103(7):2298–2303. pmid:16467144
- View Article
- PubMed/NCBI
- Google Scholar
16. Wang T, Rowland JG, Parmar J, Nesterova M, Seki T, Rainey WE. Comparison of aldosterone production among human adrenocortical cell lines. Horm Metab Res 2012 Mar;44(3):245–250. pmid:22266826
- View Article
- PubMed/NCBI
- Google Scholar
17. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003 Jun;4(6):609–615. pmid:12776180
- View Article
- PubMed/NCBI
- Google Scholar
18. Doghman M, Karpova T, Rodrigues GA, Arhatte M, De Moura J, Cavalli LR, et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 2007 Dec;21(12):2968–2987. pmid:17761949
- View Article
- PubMed/NCBI
- Google Scholar
19. Nogueira EF, Xing Y, Morris CA, Rainey WE. Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis. J Mol Endocrinol 2009 Apr;42(4):319–330. pmid:19158234
- View Article
- PubMed/NCBI
- Google Scholar
20. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009 Apr;55(4):611–622. pmid:19246619
- View Article
- PubMed/NCBI
- Google Scholar
21. Bustin SA, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, et al. The need for transparency and good practices in the qPCR literature. Nat Methods 2013 Oct 30;10(11):1063–1067. pmid:24173381
- View Article
- PubMed/NCBI
- Google Scholar
22. Bustin SA. Why the need for qPCR publication guidelines?—The case for MIQE. Methods 2010 Apr;50(4):217–226. pmid:20025972
- View Article
- PubMed/NCBI
- Google Scholar
23. Haring R, Wallaschofski H, Teumer A, Kroemer H, Taylor AE, Shackleton CH, et al. A SULT2A1 genetic variant identified by GWAS as associated with low serum DHEAS does not impact on the actual DHEA/DHEAS ratio. J Mol Endocrinol 2012 Dec 31;50(1):73–77. pmid:23132913
- View Article
- PubMed/NCBI
- Google Scholar
24. Milenkovic T, Zdravkovic D, Savic N, Todorovic S, Mitrovic K, Koehler K, et al. Triple A syndrome: 32 years experience of a single centre (1977–2008). Eur J Pediatr 2010 Nov;169(11):1323–1328. pmid:20499090
- View Article
- PubMed/NCBI
- Google Scholar
25. Tsigos C. Isolated glucocorticoid deficiency and ACTH receptor mutations. Arch Med Res 1999 Nov-Dec;30(6):475–480. pmid:10714360
- View Article
- PubMed/NCBI
- Google Scholar
26. Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, et al. Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci U S A 1992 Feb 15;89(4):1458–1462. pmid:1741400
- View Article
- PubMed/NCBI
- Google Scholar
27. Bureik M, Lisurek M, Bernhardt R. The human steroid hydroxylases CYP1B1 and CYP11B2. Biol Chem 2002 Oct;383(10):1537–1551. pmid:12452430
- View Article
- PubMed/NCBI
- Google Scholar
28. Clark AJ, Weber A. Adrenocorticotropin insensitivity syndromes. Endocr Rev 1998 Dec;19(6):828–843. pmid:9861547
- View Article
- PubMed/NCBI
- Google Scholar
29. Alesci S, Ramsey WJ, Bornstein SR, Chrousos GP, Hornsby PJ, Benvenga S, et al. Adenoviral vectors can impair adrenocortical steroidogenesis: clinical implications for natural infections and gene therapy. Proc Natl Acad Sci U S A 2002 May 28;99(11):7484–7489. pmid:12032309
- View Article
- PubMed/NCBI
- Google Scholar
30. Matkovic U, Pacenti M, Trevisan M, Palu G, Barzon L. Investigation on human adrenocortical cell response to adenovirus and adenoviral vector infection. J Cell Physiol 2009 Jul;220(1):45–57. pmid:19202555
- View Article
- PubMed/NCBI
- Google Scholar
31. Rass U, Ahel I, West SC. Actions of aprataxin in multiple DNA repair pathways. J Biol Chem 2007 Mar 30;282(13):9469–9474. pmid:17276982
- View Article
- PubMed/NCBI
- Google Scholar
32. Ahel I, Rass U, El-Khamisy SF, Katyal S, Clements PM, McKinnon PJ, et al. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature 2006 Oct 12;443(7112):713–716. pmid:16964241
- View Article
- PubMed/NCBI
- Google Scholar
33. Tumbale P, Williams JS, Schellenberg MJ, Kunkel TA, Williams RS. Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity. Nature 2014 Feb 6;506(7486):111–115. pmid:24362567
- View Article
- PubMed/NCBI
- Google Scholar
34. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 2012 Jan 18;13(2):89–102. pmid:22251901
- View Article
- PubMed/NCBI
- Google Scholar
35. Misaggi R, Di Sanzo M, Cosentino C, Bond HM, Scumaci D, Romeo F, et al. Identification of H ferritin-dependent and independent genes in K562 differentiating cells by targeted gene silencing and expression profiling. Gene 2014 Feb 10;535(2):327–335. pmid:24239552
- View Article
- PubMed/NCBI
- Google Scholar
36. Thompson KJ, Fried MG, Ye Z, Boyer P, Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci 2002 May 15;115(Pt 10):2165–2177. pmid:11973357
- View Article
- PubMed/NCBI
- Google Scholar
37. Alkhateeb AA, Connor JR. Nuclear ferritin: A new role for ferritin in cell biology. Biochim Biophys Acta 2010 Aug;1800(8):793–797. pmid:20347012
- View Article
- PubMed/NCBI
- Google Scholar
38. Cai CX, Linsenmayer TF. Nuclear translocation of ferritin in corneal epithelial cells. J Cell Sci 2001 Jun;114(Pt 12):2327–2334. pmid:11493671
- View Article
- PubMed/NCBI
- Google Scholar
39. Cai C, Ching A, Lagace C, Linsenmayer T. Nuclear ferritin-mediated protection of corneal epithelial cells from oxidative damage to DNA. Dev Dyn 2008 Oct;237(10):2676–2683. pmid:18366141
- View Article
- PubMed/NCBI
- Google Scholar
40. Huebner A, Mann P, Rohde E, Kaindl AM, Witt M, Verkade P, et al. Mice lacking the nuclear pore complex protein ALADIN show female infertility but fail to develop a phenotype resembling human triple A syndrome. Mol Cell Biol 2006 Mar;26(5):1879–1887. pmid:16479006
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Allgrove J, Clayden GS, Grant DB, Macaulay JC. Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1978 Jun 17;1(8077):1284–1286. pmid:78049
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Tullio-Pelet A, Salomon R, Hadj-Rabia S, Mugnier C, de Laet MH, Chaouachi B, et al. Mutant WD-repeat protein in triple-A syndrome. Nat Genet 2000 Nov;26(3):332–335. pmid:11062474
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Handschug K, Sperling S, Yoon SJ, Hennig S, Clark AJ, Huebner A. Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Mol Genet 2001 Feb 1;10(3):283–290. pmid:11159947
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002 Sep 2;158(5):915–927. pmid:12196509
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Cronshaw JM, Matunis MJ. The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Proc Natl Acad Sci U S A 2003 May 13;100(10):5823–5827. pmid:12730363
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Krumbholz M, Koehler K, Huebner A. Cellular localization of 17 natural mutant variants of ALADIN protein in triple A syndrome—shedding light on an unexpected splice mutation. Biochem Cell Biol 2006 Apr;84(2):243–249. pmid:16609705
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Koehler K, Brockmann K, Krumbholz M, Kind B, Bonnemann C, Gartner J, et al. Axonal neuropathy with unusual pattern of amyotrophy and alacrima associated with a novel AAAS mutation p.Leu430Phe. Eur J Hum Genet 2008 Dec;16(12):1499–1506. pmid:18628786
View Article
PubMed/NCBI
Google Scholar

[26] View Article

[27] PubMed/NCBI

[28] Google Scholar

[ref8] 8. Kind B, Koehler K, Lorenz M, Huebner A. The nuclear pore complex protein ALADIN is anchored via NDC1 but not via POM121 and GP210 in the nuclear envelope. Biochem Biophys Res Commun 2009 Dec 11;390(2):205–210. pmid:19782045
View Article
PubMed/NCBI
Google Scholar

[30] View Article

[31] PubMed/NCBI

[32] Google Scholar

[ref9] 9. Yamazumi Y, Kamiya A, Nishida A, Nishihara A, Iemura S, Natsume T, et al. The transmembrane nucleoporin NDC1 is required for targeting of ALADIN to nuclear pore complexes. Biochem Biophys Res Commun 2009 Nov 6;389(1):100–104. pmid:19703420
View Article
PubMed/NCBI
Google Scholar

[34] View Article

[35] PubMed/NCBI

[36] Google Scholar

[ref10] 10. Rabut G, Doye V, Ellenberg J. Mapping the dynamic organization of the nuclear pore complex inside single living cells. Nat Cell Biol 2004 Nov;6(11):1114–1121. pmid:15502822
View Article
PubMed/NCBI
Google Scholar

[38] View Article

[39] PubMed/NCBI

[40] Google Scholar

[ref11] 11. Kind B, Koehler K, Krumbholz M, Landgraf D, Huebner A. Intracellular ROS level is increased in fibroblasts of triple A syndrome patients. J Mol Med (Berl) 2010 Dec;88(12):1233–1242. pmid:20706703
View Article
PubMed/NCBI
Google Scholar

[42] View Article

[43] PubMed/NCBI

[44] Google Scholar

[ref12] 12. Prasad R, Metherell LA, Clark AJ, Storr HL. Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Endocrinology 2013 Sep;154(9):3209–3218. pmid:23825130
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref13] 13. Koehler K, End K, Kind B, Landgraf D, Mitzscherling P, Huebner A. Changes in differential gene expression in fibroblast cells from patients with triple A syndrome under oxidative stress. Horm Metab Res 2013 Feb;45(2):102–108. pmid:23315990
View Article
PubMed/NCBI
Google Scholar

[50] View Article

[51] PubMed/NCBI

[52] Google Scholar

[ref14] 14. Storr HL, Kind B, Parfitt DA, Chapple JP, Lorenz M, Koehler K, et al. Deficiency of ferritin heavy-chain nuclear import in triple a syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol Endocrinol 2009 Dec;23(12):2086–2094. pmid:19855093
View Article
PubMed/NCBI
Google Scholar

[54] View Article

[55] PubMed/NCBI

[56] Google Scholar

[ref15] 15. Hirano M, Furiya Y, Asai H, Yasui A, Ueno S. ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome. Proc Natl Acad Sci U S A 2006 Feb 14;103(7):2298–2303. pmid:16467144
View Article
PubMed/NCBI
Google Scholar

[58] View Article

[59] PubMed/NCBI

[60] Google Scholar

[ref16] 16. Wang T, Rowland JG, Parmar J, Nesterova M, Seki T, Rainey WE. Comparison of aldosterone production among human adrenocortical cell lines. Horm Metab Res 2012 Mar;44(3):245–250. pmid:22266826
View Article
PubMed/NCBI
Google Scholar

[62] View Article

[63] PubMed/NCBI

[64] Google Scholar

[ref17] 17. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003 Jun;4(6):609–615. pmid:12776180
View Article
PubMed/NCBI
Google Scholar

[66] View Article

[67] PubMed/NCBI

[68] Google Scholar

[ref18] 18. Doghman M, Karpova T, Rodrigues GA, Arhatte M, De Moura J, Cavalli LR, et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 2007 Dec;21(12):2968–2987. pmid:17761949
View Article
PubMed/NCBI
Google Scholar

[70] View Article

[71] PubMed/NCBI

[72] Google Scholar

[ref19] 19. Nogueira EF, Xing Y, Morris CA, Rainey WE. Role of angiotensin II-induced rapid response genes in the regulation of enzymes needed for aldosterone synthesis. J Mol Endocrinol 2009 Apr;42(4):319–330. pmid:19158234
View Article
PubMed/NCBI
Google Scholar

[74] View Article

[75] PubMed/NCBI

[76] Google Scholar

[ref20] 20. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009 Apr;55(4):611–622. pmid:19246619
View Article
PubMed/NCBI
Google Scholar

[78] View Article

[79] PubMed/NCBI

[80] Google Scholar

[ref21] 21. Bustin SA, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, et al. The need for transparency and good practices in the qPCR literature. Nat Methods 2013 Oct 30;10(11):1063–1067. pmid:24173381
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref22] 22. Bustin SA. Why the need for qPCR publication guidelines?—The case for MIQE. Methods 2010 Apr;50(4):217–226. pmid:20025972
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

[ref23] 23. Haring R, Wallaschofski H, Teumer A, Kroemer H, Taylor AE, Shackleton CH, et al. A SULT2A1 genetic variant identified by GWAS as associated with low serum DHEAS does not impact on the actual DHEA/DHEAS ratio. J Mol Endocrinol 2012 Dec 31;50(1):73–77. pmid:23132913
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref24] 24. Milenkovic T, Zdravkovic D, Savic N, Todorovic S, Mitrovic K, Koehler K, et al. Triple A syndrome: 32 years experience of a single centre (1977–2008). Eur J Pediatr 2010 Nov;169(11):1323–1328. pmid:20499090
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref25] 25. Tsigos C. Isolated glucocorticoid deficiency and ACTH receptor mutations. Arch Med Res 1999 Nov-Dec;30(6):475–480. pmid:10714360
View Article
PubMed/NCBI
Google Scholar

[98] View Article

[99] PubMed/NCBI

[100] Google Scholar

[ref26] 26. Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, et al. Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci U S A 1992 Feb 15;89(4):1458–1462. pmid:1741400
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref27] 27. Bureik M, Lisurek M, Bernhardt R. The human steroid hydroxylases CYP1B1 and CYP11B2. Biol Chem 2002 Oct;383(10):1537–1551. pmid:12452430
View Article
PubMed/NCBI
Google Scholar

[106] View Article

[107] PubMed/NCBI

[108] Google Scholar

[ref28] 28. Clark AJ, Weber A. Adrenocorticotropin insensitivity syndromes. Endocr Rev 1998 Dec;19(6):828–843. pmid:9861547
View Article
PubMed/NCBI
Google Scholar

[110] View Article

[111] PubMed/NCBI

[112] Google Scholar

[ref29] 29. Alesci S, Ramsey WJ, Bornstein SR, Chrousos GP, Hornsby PJ, Benvenga S, et al. Adenoviral vectors can impair adrenocortical steroidogenesis: clinical implications for natural infections and gene therapy. Proc Natl Acad Sci U S A 2002 May 28;99(11):7484–7489. pmid:12032309
View Article
PubMed/NCBI
Google Scholar

[114] View Article

[115] PubMed/NCBI

[116] Google Scholar

[ref30] 30. Matkovic U, Pacenti M, Trevisan M, Palu G, Barzon L. Investigation on human adrenocortical cell response to adenovirus and adenoviral vector infection. J Cell Physiol 2009 Jul;220(1):45–57. pmid:19202555
View Article
PubMed/NCBI
Google Scholar

[118] View Article

[119] PubMed/NCBI

[120] Google Scholar

[ref31] 31. Rass U, Ahel I, West SC. Actions of aprataxin in multiple DNA repair pathways. J Biol Chem 2007 Mar 30;282(13):9469–9474. pmid:17276982
View Article
PubMed/NCBI
Google Scholar

[122] View Article

[123] PubMed/NCBI

[124] Google Scholar

[ref32] 32. Ahel I, Rass U, El-Khamisy SF, Katyal S, Clements PM, McKinnon PJ, et al. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature 2006 Oct 12;443(7112):713–716. pmid:16964241
View Article
PubMed/NCBI
Google Scholar

[126] View Article

[127] PubMed/NCBI

[128] Google Scholar

[ref33] 33. Tumbale P, Williams JS, Schellenberg MJ, Kunkel TA, Williams RS. Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity. Nature 2014 Feb 6;506(7486):111–115. pmid:24362567
View Article
PubMed/NCBI
Google Scholar

[130] View Article

[131] PubMed/NCBI

[132] Google Scholar

[ref34] 34. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 2012 Jan 18;13(2):89–102. pmid:22251901
View Article
PubMed/NCBI
Google Scholar

[134] View Article

[135] PubMed/NCBI

[136] Google Scholar

[ref35] 35. Misaggi R, Di Sanzo M, Cosentino C, Bond HM, Scumaci D, Romeo F, et al. Identification of H ferritin-dependent and independent genes in K562 differentiating cells by targeted gene silencing and expression profiling. Gene 2014 Feb 10;535(2):327–335. pmid:24239552
View Article
PubMed/NCBI
Google Scholar

[138] View Article

[139] PubMed/NCBI

[140] Google Scholar

[ref36] 36. Thompson KJ, Fried MG, Ye Z, Boyer P, Connor JR. Regulation, mechanisms and proposed function of ferritin translocation to cell nuclei. J Cell Sci 2002 May 15;115(Pt 10):2165–2177. pmid:11973357
View Article
PubMed/NCBI
Google Scholar

[142] View Article

[143] PubMed/NCBI

[144] Google Scholar

[ref37] 37. Alkhateeb AA, Connor JR. Nuclear ferritin: A new role for ferritin in cell biology. Biochim Biophys Acta 2010 Aug;1800(8):793–797. pmid:20347012
View Article
PubMed/NCBI
Google Scholar

[146] View Article

[147] PubMed/NCBI

[148] Google Scholar

[ref38] 38. Cai CX, Linsenmayer TF. Nuclear translocation of ferritin in corneal epithelial cells. J Cell Sci 2001 Jun;114(Pt 12):2327–2334. pmid:11493671
View Article
PubMed/NCBI
Google Scholar

[150] View Article

[151] PubMed/NCBI

[152] Google Scholar

[ref39] 39. Cai C, Ching A, Lagace C, Linsenmayer T. Nuclear ferritin-mediated protection of corneal epithelial cells from oxidative damage to DNA. Dev Dyn 2008 Oct;237(10):2676–2683. pmid:18366141
View Article
PubMed/NCBI
Google Scholar

[154] View Article

[155] PubMed/NCBI

[156] Google Scholar

[ref40] 40. Huebner A, Mann P, Rohde E, Kaindl AM, Witt M, Verkade P, et al. Mice lacking the nuclear pore complex protein ALADIN show female infertility but fail to develop a phenotype resembling human triple A syndrome. Mol Cell Biol 2006 Mar;26(5):1879–1887. pmid:16479006
View Article
PubMed/NCBI
Google Scholar

[158] View Article

[159] PubMed/NCBI

[160] Google Scholar

Figures

Abstract

Introduction

Materials and Methods

Plasmids and vector construction for short hairpin RNA silencing of gene expression and over-expression

Cell culture and treatments

Stable and transient adrenal cell transfection

RNA extraction, cDNA synthesis and quantitative real-time PCR using TaqMan

Immunoblots

Chromatographic and mass spectrometric conditions and sample preparation

Cell Viability Assay

Measurement of total and oxidised glutathione

Hydrogen Peroxide Assay

Nuclear import processes and microscopy

Statistics

Results

Establishment of two different ALADIN expression models

Deprivation of ALADIN leads to impairment of glucocorticoid and androgenic steroidogenesis and cytochrome P450 oxidoreductase

The redox homeostasis of the cell is altered by ALADIN knock-down under exogenous oxidative stress

Cell viability with and without exogenous oxidative stress

GSH/GSSG ratio with exogenous oxidative stress

Hydrogen peroxide production with exogenous oxidative stress

Gene expression of glutathione reductase

The nuclear import of aprataxin, DNA ligase 1 and ferritin heavy chain 1 is disturbed by ALADIN

Nuclear import in AAAS knock-down cells

Nuclear import in AAAS over-expression cells

Discussion

Supporting Information

S1 Fig. Boxplots of the results of TaqMan analysis.

S2 Fig. Boxplots of the results of quantitative real-time PCR.

S3 Fig. Boxplots of the results of LC/MS-MS.

S4 Fig. Analysis of fluorescent microscopy of stably transfected NCI-H295R1-TR AAAS over-expression cells.

S1 Protocol. Quantitative real-time PCR using a double-stranded DNA-binding dye as reporter.

S1 Table. Real-time qPCR primer sequences.

S2 Table. LC/MS system parameters.

S3 Table. Mass transitions and retention times of steroids.

Acknowledgments

Author Contributions

References